Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
- PMID: 25057578
- Bookshelf ID: NBK223725
- DOI: 10.17226/10208
Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
Excerpt
In this report, the Immunization Safety Review committee examines the hypothesis of whether or not the use of vaccines containing the preservative thimerosal can cause neurodevelopmental disorders (NDDs), specifically autism, attention deficit/hyperactivity disorder (ADHD), and speech or language delay. Autism is a complex, severe developmental disorder characterized by impairments of social interaction, communication, and behavior. ADHD is a behavioral disorder characterized by persistent patterns of inattention and/or hyperactivity. Speech or language delay refers to several disorders characterized by significant impairments in vocabulary and difficulty in forming sentences, comprehending words or sentences, or forming age-appropriate speech sounds.
Copyright 2001 by the National Academy of Sciences. All rights reserved.
Sections
- THE NATIONAL ACADEMIES
- IMMUNIZATION SAFETY REVIEW COMMITTEE
- REVIEWERS
- Foreword
- Acknowledgments
- Executive Summary
- Immunization Safety Review. Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary
- Appendix B Monday, July 16, 2001 Meeting Agenda
- Appendix C Thimerosal Content in Licensed Vaccines
- APPENDIX D Immunization Safety Review Committee Biosketches
Publication types
LinkOut - more resources
Full Text Sources
